This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
Astronics Corporation (ATRO) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Astronics (ATRO) delivered earnings and revenue surprises of +15.15% and -1.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ATRONegative Net Change AVAVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Helmerich & Payne (HP) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helmerich & Payne (HP) delivered earnings and revenue surprises of +10.00% and +4.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HPPositive Net Change ARRYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Leslie's, Inc. (LESL) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Leslies (LESL) delivered earnings and revenue surprises of -4.76% and -0.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LESLNegative Net Change TBBBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Occidental Petroleum (OXY) Q2 Earnings Beat Estimates
by Zacks Equity Research
Occidental (OXY) delivered earnings and revenue surprises of +39.29% and -0.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OXYNegative Net Change EPSNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -18.75% and -55.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VYGRNegative Net Change IMNMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
APA (APA) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
APA (APA) delivered earnings and revenue surprises of +93.33% and +26.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
APANegative Net Change LNGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CACI International (CACI) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CACI International (CACI) delivered earnings and revenue surprises of +28.44% and +0.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CACINegative Net Change FORANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
American International Group (AIG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
American International Group (AIG) delivered earnings and revenue surprises of +14.56% and +0.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AIGPositive Net Change PKSTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TKO Group Holdings (TKO) Lags Q2 Earnings Estimates
by Zacks Equity Research
TKO Group (TKO) delivered earnings and revenue surprises of -4.88% and +8.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TKONegative Net Change WMGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Transcat, Inc. (TRNS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Transcat (TRNS) delivered earnings and revenue surprises of +47.50% and +5.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TRNSPositive Net Change THRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MediaAlpha, Inc. (MAX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
MediaAlpha (MAX) delivered earnings and revenue surprises of +6.25% and +2.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MAXPositive Net Change ARBENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
McKesson (MCK) delivered earnings and revenue surprises of +0.36% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MCKPositive Net Change COOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MetLife (MET) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -7.76% and -2.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
METPositive Net Change AGOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
National Health Investors (NHI) Tops Q2 FFO Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of +5.17% and -1.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NHIPositive Net Change SOHONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of -3.77% and -46.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PTGXNegative Net Change DVAXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
AnaptysBio (ANAB) delivered earnings and revenue surprises of +10.67% and +36.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ANABNegative Net Change AGENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AppLovin (APP) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AppLovin (APP) delivered earnings and revenue surprises of +13.57% and +3.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
APPNegative Net Change QXONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amdocs (DOX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Amdocs (DOX) delivered earnings and revenue surprises of +0.58% and +1.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DOXPositive Net Change SAICNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
e.l.f. Beauty (ELF) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of +5.95% and +0.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ELFNegative Net Change COTYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HubSpot (HUBS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HubSpot (HUBS) delivered earnings and revenue surprises of +3.30% and +2.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HUBSNegative Net Change BRZENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Paycom Software (PAYC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Paycom (PAYC) delivered earnings and revenue surprises of +15.73% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PAYCPositive Net Change RSKDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Staar Surgical (STAA) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Staar Surgical (STAA) delivered earnings and revenue surprises of +87.50% and +6.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STAANegative Net Change BDXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Alto Ingredients (ALTO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of +16.67% and +0.10%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALTONegative Net Change SPBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Corpay (CPAY) Meets Q2 Earnings Estimates
by Zacks Equity Research
Corpay (CPAY) delivered earnings and revenue surprises of 0.00% and +0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CPAYPositive Net Change CRGONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Federal Realty Investment Trust (FRT) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Federal Realty Investment Trust (FRT) delivered FFO and revenue surprises of +10.40% and +0.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FRTPositive Net Change MACPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank